Some companies sell products that are supposed to boost metabolism. Most say they do so through a process called thermogenesis or increased heat production. This process stimulates energy use and can increase metabolism and help burn calories. The treatment is a controlled metabolic accelerator (CMA) to treat liver fat and total body fat in patients with non-alcoholic fatty liver disease (NAFLD), while the metabolic trial was a 61-day randomized, double-blind, placebo-controlled study that investigated treatment at various doses.
By supporting the resting metabolic rate, it helps create an environment more conducive to burning fat during the night. Rivus, a company specializing in improving cardiometabolic health, has announced the results of its phase 2a trial in which the safety and effectiveness of its HU6 candidate were evaluated.